To Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function Subjects

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This study aims to evaluate the pharmacokinetics, pharmacodynamics, safety, and tolerability of ADC189 in subjects with hepatic impairment compared with subjects with normal hepatic function.
Epistemonikos ID: 8a91188631aeb7ab24459af3100135038f60caae
First added on: Apr 17, 2025